Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

NCT00048763 is registered in ClinicalTrials.gov with Otsuka America Pharmaceutical as lead sponsor.

NCT NCT00048763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
Lead sponsor
Otsuka America Pharmaceutical
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2001
Completion date
June 30, 2003
Enrollment
75
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

raynaud's disease